TCIM
EVLO

TIAA CREF Investment Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

TIAA CREF Investment Management’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$138K Sell
865
-14
-2% -$2.77K ﹤0.01% 2927
2018
Q4 		$229K Buy
+879
New +$177K ﹤0.01% 2848

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

TIAA CREF Investment Management's EVLO Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Evelo Biosciences, Inc. Common Stock (EVLO) stake by 1.6% in Q1 2019, selling an estimated $2.77K and leaving 865 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #2927.

TIAA CREF Investment Management first reported a position in EVLO in Q4 2018 and has held it in 2 quarters since. The position peaked at $229K in Q4 2018. 41 funds tracked by Wall St. Rank hold EVLO as of Q1 2019.

  • TIAA CREF Investment Management held 865 shares of Evelo Biosciences, Inc. Common Stock worth $138K as of Q1 2019.
  • TIAA CREF Investment Management sold 14 Evelo Biosciences, Inc. Common Stock shares in Q1 2019, an estimated $2.77K.
  • Evelo Biosciences, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2927 holding.
  • TIAA CREF Investment Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2018 and has held it in 2 quarters since.
  • TIAA CREF Investment Management's Evelo Biosciences, Inc. Common Stock position peaked at $229K in Q4 2018.
  • 41 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.